Takeda Pharmaceutical Co., the manufacturer of Actos, proposed $2.2 billion to settle thousands of lawsuits, according to Bloomberg. As of April 2015 more than 8,000 lawsuits had been filed against the diabetes medicine claiming hidden cancer risks.
Topics: Health, Actos, FDA, Actos Lawsuit, Diabetes, Diabetes Drug, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Diabetes Drug Lawsuit